[Ip-health] Netherlands assures India to sort out drug seizure issue

Sandeep.Rathod@matrixlabsindia.com Sandeep.Rathod@matrixlabsindia.com
Tue Feb 10 13:13:18 2009


This is a multipart message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
http://www.hindu.com/thehindu/holnus/002200902102017.htm

Netherlands assures India to sort out drug seizure issue
New Delhi (PTI): The Netherlands on Tuesday assured New Delhi that it will
sort out the issue of frequent seizure of generic drugs produced in India
by European countries on the pretext of patent protection.
Dutch Foreign Trade Minister Frank Heemskerk's, who is on a week-long
visit to India, said patent protection should not be used as an excuse for
hampering the distribution of generic drugs among the poor people across
the globe.
Recently European authorities had confiscated a ship-load of Indian
medicines on the way to Brazil and Columbia on the charges of patent
infringement, which evoked a sharp reaction from India and Brazil.
"It was some technical issue, there were some EU regulations and we should
sort out this because the Netherlands is very important transit hub (for
drugs) and there should be no unclarity between EU regulations and Trade
Related Intellectual Property Rights," Heemskerk said. He also assured
that it would worked towards sorting out the issue.
The issue came up during the meeting of Commerce and Industry Minister
Kamal Nath and the Dutch minister. "I have raised our concern on the
seizure of pharmaceutical consignment in the Netherlands and he has
assured me that his government will look into the matter expeditiously,"
Nath said.
DISCLAIMER
(i) The information contained in this e-mail message is intended only for the confidential use of the recipient(s)
named above. This message is privileged and confidential. If the reader of this message is not the intended recipient
or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this
document in error and that any review use, dissemination distribution, transmission, printing, copying, alteration, or
circulation of this message is strictly prohibited.
(ii) The sender confirms that matrix Laboratories Limited shall not be responsible if this email message is used for any
indecent, unsolicited or illegal purposes, which is in violation of any existing laws and the same shall solely be the
responsibility of the recipient and that matrix Laboratories Limited shall at all times be indemnified against any civil
and/ or criminal liabilities or consequences thereof by such recipient
--